Seattle, WA, US
Small Business (1-10M TTM Revenue)
CARDEAS PHARMA IS DEVELOPING A NOVEL ANTIBIOTIC FORMULATION OF TWO DRUGS WITH SYNERGISTIC ACTIVITY AGAINST ALL RELEVANT, HIGHLY RESISTANT GRAM-NEGATIVE BACILLI.
|Cardeas Pharma 2025 1st Avenue Seattle, WA, 98121 United States
If your organization has a Scientist.com marketplace, you can log in here to order products and services directly. If you're interested in ordering custom research services from suppliers in the Scientist.com network, book a meeting with our team here. To order products instantly, request access below.